SGRX — Sangrix Cashflow Statement
0.000.00%
Annual cashflow statement for Sangrix, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.17 | -28.2 | -18.3 | -4.37 | -14.3 |
| Depreciation | |||||
| Non-Cash Items | 7.75 | 14.9 | 13.6 | 1.98 | 11.6 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -20.2 | 1.19 | -4.17 | 0.102 | -0.237 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -14.3 | -6.76 | -7.93 | -2.29 | -2.92 |
| Capital Expenditures | -8.3 | -0.115 | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -3 | 4.38 | 1.02 | 1.55 | -0.2 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -11.3 | 4.27 | 1.02 | 1.55 | -0.2 |
| Financing Cash Flow Items | -9.05 | 0.128 | -0.596 | -0.609 | -0.646 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 26 | 2.49 | 8.3 | -0.609 | 4.64 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.388 | -0.002 | 1.39 | -1.35 | 1.51 |